Monoclonal antibodies (mAbs) are subject to instability issues linked to their protein nature.
In this work, we review the different mechanisms that can be linked to monoclonal antibodies …

Over the past several decades, great progresses have been made for the pharmaceutical
industry of monoclonal antibody (mAb). More and more mAb products were approved for …

The use of continuous infusion to improve the therapeutic efficacy of time-dependent
antibiotics has been demonstrated. There is still a lack of data to safely perform these …

As it is an important challenge for pharmacists to access the stability of monoclonal
antibodies because of the widespread of centralized preparation units, we conducted a …

Myopia is an ophthalmic condition affecting more than 1/5th of the world population,
especially children. Low-dose atropine eyedrops have been shown to limit myopia evolution …

The physical/chemical stability and potential interactions after diluting two immunoglobulin
G1 monoclonal antibodies (mAb), pertuzumab (Perjeta®) and trastuzumab (Herceptin®), in …

Objectives To gather all published information about the stability of drugs commonly used in
Intensive Care Units (ICU); evaluate the methodology of published data; and generate a …

Objectives Concerns regarding the clinical impact of meropenem instability in continuous
infusion (CI) devices may contribute to inconsistent uptake of this method of administration …

Monoclonal antibody (Mabs) containing medicinal products are widely used in clinical
practice. Prior to parenteral administration, licensed Mab containing medicinal products are …

The knowledge of the chemical stability of drugs prepared and administered in hospital is of
paramount importance for establishing the methods and times of their preparation, as well …